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The presence of the prion agent in skeletal muscle is thought to be due to the infection of nerve fibers located
within the muscle. We report here that the pathological isoform of the prion protein, PrPSc, accumulates within
skeletal muscle cells, in addition to axons, in the tongue of hamsters following intralingual and intracerebral
inoculation of the HY strain of the transmissible mink encephalopathy agent. Localization of PrPSc to the
neuromuscular junction suggests that this synapse is a site for prion agent spread between motor axon
terminals and muscle cells. Following intracerebral inoculation, the majority of PrPSc in the tongue was found
in the lamina propria, where it was associated with sensory nerve fibers in the core of the lingual papillae.
PrPSc staining was also identified in the stratified squamous epithelium of the lingual mucosa. These findings
indicate that prion infection of skeletal muscle cells and the epithelial layer in the tongue can be established
following the spread of the prion agent from nerve terminals and/or axons that innervate the tongue. Our data
suggest that ingestion of meat products containing prion-infected tongue could result in human exposure to the
prion agent, while sloughing of prion-infected epithelial cells at the mucosal surface of the tongue could be a
mechanism for prion agent shedding and subsequent prion transmission in animals.
In prion diseases, the prion agent is primarily found in the
lymphoreticular and nervous systems (8, 23). In both natural and
experimental prion infections, the prion agent is commonly am-
plified by replicating in the lymphoreticular system prior to entry
into nerve cells and subsequent invasion of the brain (1, 18, 23).
Spread within the nervous system can occur by transport along
axons and between synaptically linked neurons. Experimental
studies have demonstrated that the initial pattern of prion agent
spread in the spinal cord and brain follows defined autonomic,
sensory, and motor pathways (3, 4, 12, 13, 27).
Modest levels of prion agent replication in skeletal muscle
have been reported in a few studies following intracerebral or
extraneural inoculation of the prion agent. Prion infectivity in
skeletal muscle was first demonstrated in mink with transmis-
sible mink encephalopathy (TME); the amount of infectious
agent in skeletal muscle was 10,000-fold less than the amount
found in brain (26). Prion infectivity or accumulation of the
abnormal form of the prion protein, PrPSc, in skeletal muscle
has more recently been described in experimental prion infec-
tion of rodents and in sporadic Creutzfeldt-Jakob disease
(CJD) of humans (14), but the cellular location of agent dep-
osition and/or replication in muscle has not been identified (3,
6, 40). In natural prion diseases, PrPSc is found in the periph-
eral nervous system of scrapie-infected sheep and goats, and it
has been proposed that it is the peripheral nerves which trans-
verse skeletal muscle that are the source of prion infectivity in
muscle (16, 17, 19, 20). Attempts to measure the prion agent in
muscle of goats infected with the scrapie agent (18, 20) and
cattle infected with the bovine spongiform encephalopathy
(BSE) agent (10, 42) have not detected prion infectivity. How-
ever, a murine bioassay was used to measure prion infectivity
in these studies, and this assay cannot detect below 104.1 lethal
median doses (LD50) of the BSE agent (10, 42). Therefore, low
levels of prion agent that could be present in muscle tissue of
domestic livestock would not be found using this bioassay.
Routine testing for PrPSc in brains from cattle in Europe and
in lymph nodes from deer and elk in the United States has
been implemented to reduce human exposure to BSE and
chronic wasting disease by removing infected animals from the
food supply. However, human consumption of skeletal muscle
from a prion-infected animal is currently considered a low risk
for contracting a prion disease.
In this study, we report that in hamsters infected with the
TME agent, by either an intralingual or intracerebral route,
PrPSc can accumulate in skeletal muscle cells of the tongue.
Localization of PrPSc to the neuromuscular junction (NMJ)
indicates that this synapse can be a site for prion agent repli-
cation and may provide a path by which the prion agent
spreads between skeletal muscle cells and axon terminals.
PrPSc was also found in the lingual papillae of the tongue,
specifically in nerve fibers of the lamina propria and in the
stratified squamous epithelium of the tongue surface. These
findings have public health implications and suggest that (i)
ingestion of prion-infected tongue could be a source of prion
exposure for humans, since livestock tongue is not included in
the specified risk material; and (ii) normal shedding of the
outer layer of the tongue epithelium can release the prion
agent into saliva, which may be a source for prion agent trans-
mission in livestock and cervids.
MATERIALS AND METHODS
Animal inoculations. All procedures involving animals were approved by the
Creighton University Institutional Animal Care and Use Committee and were in
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compliance with the Guide for the Care and Use of Laboratory Animals (31).
Hamsters were inoculated in the lingual muscles of the tongue or the cerebrum
with 20 l of a brain homogenate from a TME-infected hamster which contained
107.5 intracerebral LD50 per ml of the HY TME agent. Following inoculation
with the HY TME agent, hamsters were observed three times per week for the
onset of clinical symptoms. Hamsters were euthanized at either specific intervals
postinfection or after the onset of disease. In the latter case, animals were culled
at 75 to 85 days postinfection for the intracerebral inoculation group and at 95
to 105 days for the intratongue inoculation group. Tongue and brain were
collected for PrPSc analysis by Western blotting and immunohistochemistry. At
least two independent mock-infected and HY TME-infected tissue samples were
used for each of these analyses, but three or more tissue samples were typically
used in each study. Western blotting and immunohistochemistry results were
similar among individual animals within each control and experimental group.
Tissue preparation for PrPSc Western blotting. PrPSc was enriched from
tongue prior to Western blotting by tissue extraction in detergent and differential
ultracentrifugation as previously described (3, 4). PrPSc-enriched samples were
digested with proteinase K and resuspended in sodium dodecyl sulfate-polyac-
rylamide gel electrophoresis (SDS-PAGE) sample loading buffer. Five-percent
brain homogenates were also digested with proteinase K and prepared for
Western blotting as previously described (4). SDS-PAGE and Western blot
analysis were performed using monoclonal antibody 3F4 hybridoma supernatant
(22) (a gift of Victoria Lawson, NIH Rocky Mountain Labs, Hamilton, Mont.) as
previously described. Quantification of PrPSc signal in Western blot assays was
performed using ImageQuant software as previously described (4).
PrPSc immunohistochemistry, immunofluorescence, and confocal microscopy.
Immunostaining for PrPSc in tongue was performed as previously described (3).
Briefly, animals were intracardially perfused with paraformaldehye-lysine-perio-
date fixative followed by postfixation in paraformaldehye-lysine-periodate for
5 h. Paraffin-embedded tissue sections (4 m) were subjected to antigen retrieval
by pretreatment with formic acid for 20 min. A minimum of 10 tissue sections per
animal was examined for each antibody staining procedure. PrPSc was detected
by incubation with monoclonal 3F4 hybridoma supernatant (1:600 dilution) and
the ABC-horseradish peroxidase Elite staining method (Vector Laboratories,
Burlingame, Calif.). For PrPSc staining in the double immunofluorescence pro-
cedure, the ABC-horseradish peroxidase incubation step in the ABC method was
replaced by incubation with an Alexa Fluor 488 streptavidin conjugate (Molec-
ular Probes, Portland, Oreg.) at a 1:400 dilution. PrPSc immunofluorescence
staining was combined with rabbit polyclonal antibody staining for either desmin
(1:50 dilution; DAKO Corp., Carpinteria, Calif.), synaptophysin (1:50 dilution;
DAKO Corp.), S100 (1:800 dilution; DAKO Corp.), cytokeratin (1:800 dilution;
DAKO Corp.), or calcitonin growth-related peptide (CGRP; 1:125 dilution;
Peninsula Labs, Inc., San Carlos, Calif.). This latter group of primary antibodies
was visualized by incubation with anti-rabbit antibody conjugated to Alexa Fluor
568 (Molecular Probes). The nuclear counterstain TO-PRO3 (Molecular
Probes) was applied to some tissue sections at a concentration of 0.25 M for 10
min. Tissue sections were mounted with Vectashield Antifade (Vector Labora-
tories). Images were visualized with epifluorescence using a Bio-Rad Radiance
2000 confocal system attached to a Nikon Eclipse 800 microscope.
RESULTS
Inoculation of the HY TME agent into the lingual muscles
of the tongue and the cerebrum resulted in incubation periods
of 83  3 days and 62  2 days, respectively, in Golden Syrian
hamsters (mean standard error of the mean). At the onset of
clinical symptoms, both groups had evidence of PrPSc deposi-
tion in the tongue (Fig. 1). Quantification of the PrPSc
polypeptide bands using ImageQuant software indicated that
the amount of PrPSc in the tongue was approximately fourfold
higher following intratongue inoculation than that following
intracerebral inoculation. However, the amount of PrPSc in the
brain was approximately 1,000-fold higher than that found in
comparable amounts of TME-infected tongue following either
route of inoculation (Fig. 1). Immunohistochemistry revealed
that PrPSc was located in three regions of the tongue, including
the skeletal muscle (Fig. 2B), the lamina propria of the papil-
lae (Fig. 2C), and the stratified squamous epithelium of the
tongue mucosa (see below).
Confocal microscopy was used to localize PrPSc to specific
cell types in the tongue. Following intratongue inoculation of
the HY TME agent, the majority of PrPSc staining was found
within skeletal muscle cells. This was demonstrated in the
tongues of clinically ill hamsters at greater than 95 days postin-
fection by colocalization of desmin staining (i.e., an interme-
diate filament protein in skeletal muscle cells) in PrPSc-positive
cells (Fig. 3A to C). While PrPSc was widely distributed within
skeletal muscle cells, it was often present in higher amounts at
the periphery of the cell (Fig. 3A). At 1 week postinoculation
of the tongue, PrPSc staining was found in less than three
skeletal muscle cells per tissue section; the number of PrPSc-
positive cells as well as the amount of PrPSc staining progres-
sively increased in skeletal muscle cells during the course of
subclinical TME infection (data not shown). At 95 days post-
inoculation, when hamsters were clinically affected, skeletal
muscle cells throughout the tongue were PrPSc positive. It is
worth noting that PrPSc-positive muscle cells were located be-
tween PrPSc-negative cells (Fig. 2B and 3A). These results
demonstrate that the TME agent can accumulate within skel-
etal muscle cells and suggest that replication can also occur in
these cells. At the clinical stages of TME, a lower amount of
PrPSc staining was found in skeletal muscle cells of the tongue
in hamsters that were intracerebrally inoculated compared to
those inoculated into the tongue with the HY TME agent (data
not shown). This finding was consistent with PrPSc Western
blotting data of tongue from intracerebral- and intratongue-
inoculated hamsters (Fig. 1). In mock-infected controls, spe-
cific binding of anti-PrP monoclonal 3F4 antibody was not
observed (Fig. 2A).
FIG. 1. PrPSc deposition in tongue and brain following inoculation
of the HY TME agent. Hamsters were inoculated with the TME agent
or a normal brain homogenate (mock) by either the intratongue or
intracerebral route. Tongue and brain tissues were collected from
animals that were sacrificed after the onset of clinical disease as de-
scribed in the text. PrPSc in brain homogenates or PrPSc-enriched
preparations from tongue digested with proteinase K were prepared as
described in Materials and Methods and analyzed by SDS-PAGE and
PrP Western blotting. The amount of tissue analyzed in each lane is
indicated in milligram tissue equivalents (mg eq), and the molecular
masses of polypeptides in kilodaltons are indicated to the left of the
panel.
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Previously, we demonstrated that PrPSc was associated with
axons in nerve fascicles in the tongue (3). In the present report,
PrPSc staining in nerve fascicles was demonstrated after 95
days postinfection following intratongue inoculation of HY
TME, but it did not colocalize with S100 staining, which was
used as a marker for Schwann cells (Fig. 3D to F). This finding
suggested that the majority of PrPSc was located within the
axons in this experimental model and was less likely to be
FIG. 2. PrPSc deposition in tongue following inoculation of the HY TME agent. Hamsters were inoculated with a normal brain homogenate
(A) or the TME agent (B and C) by either the intratongue (A and B) or intracerebral (C) route. Tongues were collected from animals that were
sacrificed after the onset of clinical disease and prepared for immunohistochemistry as described in Materials and Methods. PrPSc immunohis-
tochemistry illustrated PrPSc (red punctate staining) in skeletal muscle cells (B) and the lamina propria (C) but an absence of immunostaining in
mock-infected tongue (A). The tissue was counterstained with hematoxylin. The lamina propria (LP) and stratified squamous epithelium (SSE)










FIG. 3. Confocal microscopy of PrPSc in skeletal muscle cells and axons. Hamsters were inoculated in the lingual muscles with the HY TME
agent. At the onset of clinical symptoms, the tongue was prepared for immunofluorescence staining and confocal microscopy as described in
Materials and Methods. Following immunofluorescence staining for identification of PrPSc with Alexa Fluor 488 (A, D, and G), tissue sections were
also stained for either desmin (B), S100 (E), or synaptophysin (H) with goat anti-rabbit immunoglobulin conjugated to Alexa Fluor 568. To
investigate the colocalization of PrPSc with desmin (C), S100 (F), and synaptophysin (I), green and red fluorescent images were merged. Bar, 10
m. The insets at the lower left corner (C, F, and I) are two- to threefold enlargements of smaller boxes in each of the corresponding panels.
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within the Schwann cells that surround axons in the peripheral
nervous system. Both large nerve fascicles that travel between
skeletal muscle fascicles and small nerve fascicles located in
the lamina propria were found to contain punctate PrPSc stain-
ing following intratongue inoculation.
The spatial relationship between PrPSc and the NMJ was
investigated following intratongue inoculation of the HY TME
agent, since PrPSc was found in both skeletal muscle cells and
axons in the tongue. An antibody to synpatophysin, a marker
for synaptic vesicles in the axon terminal, was used for identi-
fication of NMJs in hamster tongue from clinically ill hamsters
at 95 days postinfection. Sixty-four percent of synaptophysin-
positive skeletal muscle cells were also PrPSc positive; colocal-
ization of synaptophysin and PrPSc was found in 25% of these
cells (Fig. 3G to I). In the example illustrated (Fig. 3G to I),
PrPSc staining was localized to the NMJ, indicating that this is
one potential site for PrPSc accumulation in skeletal muscle
cells and/or axon terminals.
The majority of PrPSc staining in the lingual mucosa was
located in the lamina propria following intracerebral inocula-
tion of HY TME, especially within the connective tissue core
of the lingual papillae (Fig. 2C). To investigate the spatial
relationship between PrPSc and nerve fibers in the lamina pro-
pria, we examined PrPSc and CGRP staining in the tongue at
75 to 85 days postinfection following intracerebral inoculation
of the HY TME agent. CGRP staining in the lamina propria
was used to identify a subset of sensory nerves, since not all
sensory fibers are CGRP positive. PrPSc immunostaining was
identified in 35% of CGRP-positive papillae, but colocaliza-
tion of CGRP and PrPSc was found in only 5% of CGRP-
positive papillae (Fig. 4A to C). In 4% of the lingual papillae,
PrPSc staining was also found in the stratified squamous epi-
thelium of the tongue mucosa following intracerebral inocula-
tion (Fig. 4D). In these examples, the PrPSc and cytokeratin
staining were in close proximity in the papillary epithelium
(Fig. 4D to F); cytokeratin immunohistochemistry was used as
a marker for the stratified squamous epithelial cells of the
tongue. However, there was no direct overlap of the two stain-
ing patterns (Fig. 4F, inset). A greater amount of PrPSc stain-
ing was found associated with tongue papillae following intra-
cerebral inoculation compared to inoculation of the HY TME
agent into the lingual muscles. No PrPSc-specific staining was
observed in the tongue of mock-infected hamsters (Fig. 4G to
I).
PrPSc staining in the tongue mucosa did not appear in cell
groups that had the morphology of the lingual tonsils. How-
ever, we cannot exclude the possibility that PrPSc was associ-
ated with diffuse lymphoid tissue that is found in the tongue of
some species.
DISCUSSION
In this study we report that the prion agent is located within
skeletal muscle cells following inoculation of the HY TME
agent into either the tongue or the cerebrum. While the TME
agent was distributed throughout the individual muscle cells,
PrPSc was also localized to the NMJ in 25% of synaptophysin-
positive muscle cells. These findings do not distinguish whether
the PrPSc staining was present in the presynaptic axon termi-
nal, postsynaptic skeletal muscle, or in both locations in the
NMJ. PrPSc was also identified in sensory axons of the lamina
propria, mainly in the core of the lingual papillae, but also
within the stratified squamous epithelium. This tissue distribu-
tion of the prion agent in skeletal muscle and oral mucosa has
not been previously reported.
Prior studies have demonstrated PrPSc accumulation in the
tongue (3, 40) or prion infectivity in skeletal muscle (6, 26, 40),
but PrPSc staining by immunomorphological methods has only
been reported in nerve fibers that transverse skeletal muscle
(3). In the present study, PrPSc deposition was found in nerve
fibers and skeletal muscle cells of the tongue. The normal
isoform of the prion protein, PrPC, has been demonstrated to
spread within nerve fibers by axonal transport (5) and is lo-
cated in synapses, including subsynaptic areas in both the pre-
synaptic and postsynaptic cells of the NMJ (2, 15). Since PrPC
is required for PrPSc formation (7), we propose that the NMJ
is a site for PrPSc formation and/or PrPSc spread between
skeletal muscle cells and axon terminals. In this case, PrPSc
spread to, and accumulation in, skeletal muscle cells in the
tongue following intracerebral inoculation could be due to
TME agent replication in the brain and subsequent antero-
grade transport within the hypoglossal nerve, which provides
motor innervation to the lingual muscles. PrPSc may spread
across the NMJ and enter skeletal muscle cells, where addi-
tional TME agent replication can occur, since PrPC is also
expressed in skeletal muscle cells (15, 29). This hypothesis is
supported by studies that describe (i) the spread of the prion
agent in both the anterograde and retrograde directions be-
tween synaptically linked nerve cell groups in the central ner-
vous system (4, 12, 13, 27), (ii) the retrograde transport of the
HY TME agent from the tongue to the brain in the hypoglossal
nerve following intratongue inoculation (3), and (iii) prion
infectivity in skeletal muscle of transgenic mice that express
PrPC in myocytes (6). Although the NMJ is morphologically
distinct from synapses in the central nervous system, our find-
ings are consistent with this peripheral synapse serving as a
pathway for intercellular spread of the prion agent between
motor axon terminals and muscle cells.
PrPSc deposition in the lamina propria below the mucosal
epithelium was associated with sensory nerve fibers; however,
we cannot exclude the possibility that other types of cells or
axons are infected with the TME agent, since only a portion of
PrPSc staining colocalized with CGRP staining. Given that
CGRP staining only labels a subset of sensory fibers, it is
possible that other types of sensory fibers located in the lamina
propria also contain PrPSc. Based on the location of PrPSc
staining and morphology of the adjacent tissue, there was no
evidence that PrPSc was present in the lingual tonsils, which are
also a potential target for TME agent replication. However,
from these studies we cannot exclude that the lingual tonsils
are a site of TME agent replication. PrPSc staining in the
lamina propria was often found in the connective tissue in the
core of papillae; this area has a high concentration of sensory
fibers that innervate mechanoreceptors and taste buds in the
tongue (30, 35). PrPSc staining in the lamina propria and
tongue epithelium was more pronounced following intracere-
bral inoculation compared to intralingual inoculation. This
finding could be due to TME agent replication in the brain and
subsequent transganglionic transport within the tongue-asso-
ciated sensory cranial nerves. PrPSc that was localized to cy-






FIG. 4. Confocal microscopy of PrPSc in sensory nerve fibers and the stratified squamous epithelium. Hamsters were inoculated in the cerebrum
with the HY TME agent (A to F) or a normal brain homogenate (G to I) (mock infected). At the onset of clinical symptoms, the tongue was
prepared for confocal microscopy as described in Materials and Methods. Following immunofluorescence staining for PrPSc with Alexa Fluor 488
(A, D, and G), tissue sections were stained for either CGRP (B) or cytokeratin (E and H) with goat anti-rabbit immunoglobulin conjugated to
Alexa Fluor 568. The stain TO-PRO3 was used to visualize nuclei under blue fluorescence. To investigate the colocalization of PrPSc with CGRP
(C) and cytokeratin (F and I), green and red fluorescent images were merged. Bar, 10 m. The insets at the bottom (C and F) are two- to threefold
enlargements of smaller boxes in each of the corresponding panels.
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tokeratin-positive cells could also be explained by TME infec-
tion of sensory nerve fibers that project into the epithelial cell
layers of the tongue (11, 25, 32, 38). Alternatively, prion agent
could spread to basal keratinocytes from sensory nerve endings
and lead to PrPSc formation, since keratinocytes also express
PrPC (33, 39). This proposed pathway for prion agent spread to
the mucosa along sensory fibers is analogous to the previous
reports of spread of the CJD agent from the brain to the
cornea and olfactory mucosa in sporadic CJD (24, 45; P. Duffy,
J. Wolf, G. Collins, A. G. DeVoe, B. Streeten, and D. Cowen,
Letter, N. Engl. J. Med. 290:692-693, 1974). The low level or
absence of the prion agent in the lymphoreticular system in
sporadic CJD (14, 21) suggests that the optic and olfactory
cranial nerves, respectively, transport the CJD agent from the
brain to these mucosal or exposed surfaces. Ultrastructural
studies will be necessary to further define the location of PrPSc
in the lamina propria and sensory nervous system in the tongue
and its spatial relationship to epithelial cells of the tongue.
In natural prion diseases, prion agent transport from the
brain to the tongue could have implications for human food
safety and animal prion transmission. In sheep with scrapie,
cattle with BSE, and deer with chronic wasting disease, the
brain stem regions containing the tongue-associated cranial
nerve nuclei have been reported to be targets for prion infec-
tion. In one or more of these diseases, PrPSc has been found in
the hypoglossal nucleus (9, 37, 43), the nucleus of the solitary
tract (9, 34, 37, 43), and several of the trigeminal nuclei (9, 34,
37, 43, 44). The ability of the prion agent to establish infection
in brain nuclei that contribute to, or synapse with, the four
cranial nerves that innervate the tongue suggests that this
could be a pathway for centrifugal prion agent spread. The
tongue is one of the most densely innervated extraneural tis-
sues in the human body, with a very high concentration of both
motor and sensory axons (28, 30, 35, 36, 41). Anterograde
prion transport within the hypoglossal nerve would be ex-
pected to result in prion infection of the lingual muscles, while
transganglionic transport within the trigeminal, facial, and
glossopharyngeal nerves could result in prion spread to the
sensory fibers in the tongue. It is noteworthy that prion infec-
tivity has been found in the trigeminal ganglia of sheep with
scrapie (19) and cattle with BSE (42), indicating that centrif-
ugal spread of these prion agents within the trigeminal nerve
can occur and could result in spread to peripheral sites includ-
ing the tongue. Since livestock and cervid tongues are not
banned for human consumption, it is possible that humans
could be exposed to animal prion diseases by ingestion of
prion-infected tongue. Attempts to identify prion infectivity in
bovine tongues have not been successful. However, these stud-
ies have used an infectivity bioassay that cannot detect below
104.1 LD50 of BSE prions, which may not detect low levels of
the prion agent (10, 42). Our findings also have implications
for intraspecies transmission of animal prion diseases. Estab-
lishment of prion infection in the stratified squamous epithelial
cells of the tongue, as suggested by our findings, could result in
sloughing of the prion agent into the saliva, since this tissue is
undergoing continual cell turnover. In this case, animal behav-
iors resulting in the exchange of saliva between hosts may play
a role in prion transmission.
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